Effect of Single Dose of 2L PEG on Bowel Preparation in Average-risk Patients Undergoing Colonoscopy
1 other identifier
interventional
940
1 country
3
Brief Summary
Adequate quality of bowel preparation(BP) is important for colonoscopy. Several guidelines recommend that split-dose of 4L PEG should be used as a standard regime for BP. However, the high-volume PEG still results in lower compliance to the regime and increased cost. Some high risk factors for inadequate BP have been identified, including old age, constipation, diabetes, the use of narcotics and prior history of inadequate BP. For average-risk patients without the high risk factors, the procedure of BP could be easier. In the previous study, with the use of single dose of 2L PEG, more than 90% of average-risk patients achieved adequate BP. Here investigators hypothesized that compared with the standard split dose of 4L PEG, single dose of 2L PEG may be not inferior in BP quality while may be accompanied with better tolerability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2016
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2016
CompletedStudy Start
First participant enrolled
December 1, 2016
CompletedFirst Posted
Study publicly available on registry
December 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedSeptember 13, 2017
July 1, 2017
8 months
November 30, 2016
September 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of adequate bowel preparation(defined as a total BostonBowel Preparation Score ≥6 with each segmental BBPS≥2)
The adequacy of bowel preparation is defined as Boston Bowel Preparation Scale (BBPS), a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side. They were summed to give the total BBPS score, which ranged from 0 to 9.The withdrawal procedure was recorded by vedios. The BBPS and segmental scores in each segment were judged by one endoscopist who was familiar with the criteria of BBPS and blinded to group allocation.
1 year
Secondary Outcomes (6)
Polyp detection rate
1 year
Rate of adverse events
1 year
Cecal intubation rate
1 year
Cecal intubation time
1 year
Withdrawal time
1 year
- +1 more secondary outcomes
Study Arms (2)
Single dose of 2L PEG
EXPERIMENTAL2 L of PEG solution was used on the day of colonoscopy.
Split-dose of 4L PEG
ACTIVE COMPARATORSplit-dose of 4l PEG was used before and on the day of colonoscopy
Interventions
Patients at average risk for inadequate BP were given instructions for bowel preparation through phone call a day before scheduled colonoscopy. Patients began to drink 2 L of PEG 4-6 hours before colonoscopy at a rate of 250 mL every 15 minutes.
All patients at average risk for inadequate BP were given instructions for bowel preparation through phone call a day before scheduled colonoscopy. the participants began to drink the first 2 L of PEG at 7:00-9:00 PM on the day before colonoscopy at a rate of 250 mL every 15 minutes. On the day of the procedure, patients took the remaining 2 L 4-6 hours before colonoscopy.
Eligibility Criteria
You may qualify if:
- Patients undergoing colonoscopy;
- Patients with average risks for inadequate BP (Patients were identified average-risk if they did not meet any factor of the following risk factors):
- Constipation
- Diabetes
- Parkinson's disease
- History of stroke or spine cord injure
- Prior history of inadequate bowel preparation
- BMI\>25
- Use of tricyclic antidepressant or narcotics
You may not qualify if:
- History of colorectal resection;
- Suspected colonic stricture or perforation;
- Incomplete or complete bowel obstruction;
- Use of prokinetic agents or purgatives within 7 days;
- Toxic colitis or megacolon;
- Pregnancy or lactation;
- Unable to give informed consent;
- Haemodynamically unstable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Department of gastroenterology, Qinghai Provincial People's Hospital
Xining, Qinghai, 810000, China
Department of gastroenterology, Shaanxi Second People's Hospital
Xi'an, Shaanxi, 710032, China
Endoscopic center, Xijing Hospital of Digestive Diseases
Xi’an, Shanxi, 710032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associated professor
Study Record Dates
First Submitted
November 30, 2016
First Posted
December 20, 2016
Study Start
December 1, 2016
Primary Completion
August 1, 2017
Study Completion
August 1, 2017
Last Updated
September 13, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will not share